S&P 500
7,666.60
+35.13
+0.46%
Dow
53,061.95
+295.05
+0.56%
Nasdaq
26,217.83
+118.06
+0.45%
NYSE Composite
24,495.55
+146.25
+0.60%
Russell 2000
2,953.17
+33.04
+1.13%
VIX
15.33
+0.13
+0.86%
ABBV · ABBVIE INC.
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
AbbVie Inc (ABBV)
NEW YORK STOCK EXCHANGE, INC.
Biotechnology
$261.68
+1.66
(+0.64%)
● At close: September 2 at 4:00:00 PM EDT
$262.50
+0.80
(+0.30%)
Pre-Market:
8:34:05 AM EDT
DAY'S RANGE
$261.68
$257.75
$262.89
52-WEEK RANGE
$261.68
$190.75
$267.47
What's happening
- ABBV is up 0.64% today, trading at $261.68. — Live quote
- Volume today (180,981) is well below its 3-month average of 6,365,420. (Finnhub fundamentals)
- Last quarter's EPS missed estimates: $3.65 actual vs. $3.68 estimated (-0.7%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 10
Buy 22
Hold 7
Sell 0
Strong sell 0
Aggregate ratings for 2026-09-01 (39 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ABBV
+13.79%
vs S&P 500
+2.08%
1-YEAR RETURN
ABBV
+22.68%
vs S&P 500
+3.71%
6-MONTH RETURN
ABBV
+15.71%
3-MONTH RETURN
ABBV
+22.10%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$3.65
Est. $3.68
MISS -0.7%
2026-04-26 (Q1 2026)
$2.65
Est. $2.65
BEAT +0.2%
2026-01-26 (Q4 2025)
$2.71
Est. $2.71
BEAT +0.2%
2025-10-26 (Q3 2025)
$1.86
Est. $1.81
BEAT +2.7%
Valuation Measures & Ratios
Enterprise Value4$507.48B
Forward P/E516.77
PEG Ratio66.59
Price / Sales (TTM1)6.88
Price / Book7261.01
EV4 / Revenue7.88
EV4 / EBITDA28.76
Profit Margin9.80%
Operating Margin26.20%
Return on Equity (ROE8)95.59%
Return on Assets (ROA9)4.68%
Avg Volume (3M)6,365,420
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 |
|---|---|---|---|---|---|
| Market cap | $444.36B | $381.63B | $397.38B | $417.85B | $322.06B |
| P/E | 70.42 | 104.99 | 94.03 | 174.98 | 85.59 |
| Price/Sales | 6.90 | 6.08 | 6.50 | 7.01 | 5.52 |
| Price/Book | -74.87 | -57.34 | -121.52 | -158.16 | -1759.88 |
| EV/Revenue | 6.80 | 5.93 | 7.51 | 6.97 | 5.51 |
| ROE | -106.32% | -54.61% | -129.24% | -90.39% | -2056.28% |
| ROA | 4.67% | 2.66% | 3.15% | 1.78% | 2.74% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E and PEG aren't shown here — both need historical analyst-consensus estimates, which no free source provides; see the current-period figures above instead.
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short18,299,894
Change from Prior Settlement-18.84%
% of Float—
Days to Cover (Short Ratio)3.57
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.
Indicators None active
Loading chart…
Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 10.2% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +22.7%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is 9.8%. Finnhub fundamentals ↗
- Trailing P/E is 70.2, a high price relative to reported earnings. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-08-18; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ABBV
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.99B | $15.00B | $16.62B | $15.78B | $15.42B | $13.34B | $15.10B | $14.46B |
| Gross profit | — | — | $12.07B | — | — | — | $10.71B | — |
| Operating income | $6.43B | $3.99B | — | $1.90B | $4.89B | $3.73B | — | $3.83B |
| Net income | $3.61B | $695.0M | $1.82B | $186.0M | $938.0M | $1.29B | -$22.0M | $1.56B |
| EPS (diluted) | $2.03 | $0.39 | $1.02 | $0.10 | $0.52 | $0.72 | $-0.02 | $0.88 |
| EPS (basic) | $2.04 | $0.39 | $1.02 | $0.10 | $0.52 | $0.72 | $-0.02 | $0.88 |
| Operating margin | $38 | $27 | — | $12 | $32 | $28 | — | $26 |
| Net margin | $21 | $5 | $11 | $1 | $6 | $10 | -$0 | $11 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $135.12B | $136.46B | $133.96B | $133.90B | $137.18B | $136.16B | $135.16B | $143.42B |
| Stockholders' equity | -$5.93B | -$6.66B | -$3.27B | -$2.64B | -$183.0M | $1.42B | $3.33B | $6.03B |
| Total current assets | $33.67B | $33.53B | $29.06B | $28.54B | $29.26B | $27.68B | $25.58B | $27.79B |
| Total current liabilities | $41.64B | $42.10B | $43.29B | $39.39B | $39.77B | $36.40B | $38.75B | $43.06B |
| Cash & equivalents | $6.57B | $9.39B | $5.23B | $5.63B | $6.47B | $5.17B | $5.52B | $7.26B |
| Marketable securities (current) | — | — | $28.0M | $42.0M | $0 | $1.0M | $31.0M | $28.0M |
| Accounts receivable | $13.82B | $12.48B | $12.59B | $12.77B | $12.64B | $12.48B | $10.92B | $11.47B |
| Inventory | $5.13B | $5.05B | $4.95B | $4.94B | $4.96B | $4.53B | $4.18B | $4.45B |
| Marketable securities (non-current) | $266.0M | $268.0M | $268.0M | $291.0M | $310.0M | $287.0M | $279.0M | $267.0M |
| Property, plant & equipment | $5.80B | $5.69B | $5.63B | $5.48B | $5.28B | $5.24B | $5.13B | $5.14B |
| Goodwill | $35.52B | $35.57B | $35.64B | $35.63B | $35.64B | $35.28B | $34.96B | $35.30B |
| Intangible assets | $49.14B | $50.87B | $52.64B | $54.31B | $57.03B | $58.49B | $60.07B | $66.65B |
| Other non-current assets | $10.73B | $10.54B | $10.72B | $9.64B | $9.66B | $9.19B | $9.14B | $8.29B |
| Accounts payable | — | — | $3.59B | — | — | — | $2.94B | — |
| Short-term debt | $0 | $0 | $2.50B | $3.79B | $5.56B | $1.59B | $0 | — |
| Long-term debt | — | — | $64.50B | — | — | — | $66.84B | — |
| Other non-current liabilities | $34.60B | $34.11B | $32.57B | $31.66B | $32.04B | $31.19B | $30.13B | $33.03B |
| Retained earnings | -$17.33B | -$17.87B | -$15.49B | -$14.23B | -$11.50B | -$9.53B | -$7.90B | -$4.96B |
| Accumulated other comprehensive income (loss) | -$1.16B | -$1.15B | -$1.14B | -$1.57B | -$1.54B | -$1.74B | -$1.93B | -$2.33B |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.44B | $3.83B | $5.22B | $7.02B | $5.15B | $1.64B | $7.05B | $5.45B |
| Investing cash flow | -$1.20B | -$574.0M | -$1.46B | -$3.26B | -$1.18B | -$735.0M | -$1.87B | -$8.26B |
| Financing cash flow | -$5.05B | $919.0M | -$4.17B | -$4.59B | -$2.71B | -$1.26B | -$6.86B | -$3.07B |
| Free cash flow | $3.11B | $3.56B | $4.89B | $6.64B | $4.88B | $1.40B | $6.76B | $5.20B |
| Capital expenditures | $322.0M | $265.0M | $329.0M | $381.0M | $269.0M | $235.0M | $291.0M | $249.0M |
| Share-based compensation | $166.0M | $444.0M | $157.0M | $209.0M | $179.0M | $410.0M | $164.0M | $181.0M |
| Deferred income taxes | -$195.0M | $137.0M | -$385.0M | $193.0M | -$272.0M | -$28.0M | -$767.0M | -$277.0M |
| Change in accounts receivable | $1.37B | -$87.0M | -$162.0M | $156.0M | $17.0M | $1.48B | -$387.0M | -$344.0M |
| Change in inventory | $143.0M | $184.0M | $25.0M | -$2.0M | $56.0M | $155.0M | $128.0M | $64.0M |
| Purchases of investments | — | — | $6.0M | $7.0M | $12.0M | $10.0M | $27.0M | $24.0M |
| Other investing activities | $51.0M | $43.0M | $1.0M | $94.0M | -$28.0M | -$38.0M | -$197.0M | -$3.0M |
| Dividends paid | $3.07B | $3.09B | $2.91B | $2.91B | $2.91B | $2.92B | $2.75B | $2.75B |
| Share repurchases | $9.0M | $1.49B | $3.0M | $4.0M | $12.0M | $961.0M | $358.0M | $17.0M |
| Debt issued | $0 | $7.99B | $0 | $0 | $0 | $3.99B | $2.00B | $0 |
| Other financing activities | $25.0M | $2.0M | -$1.0M | -$1.0M | $3.0M | $67.0M | $1.0M | $32.0M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $61.16B | $56.33B | $54.32B | $58.05B | $56.20B |
| Operating income | $15.07B | $9.14B | $12.76B | $18.12B | $17.92B |
| Net income | $4.23B | $4.28B | $4.86B | $11.84B | $11.54B |
| EPS (diluted) | $2.36 | $2.39 | $2.72 | $6.63 | $6.45 |
| EPS (basic) | $2.37 | $2.40 | $2.73 | $6.65 | $6.48 |
| Operating margin | $25 | $16 | $23 | $31 | $32 |
| Net margin | $7 | $8 | $9 | $20 | $21 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $133.96B | $135.16B | $134.71B | $138.81B | $146.53B |
| Stockholders' equity | -$3.27B | $3.33B | $10.36B | $17.25B | $15.41B |
| Total current assets | $29.06B | $25.58B | $33.00B | $28.46B | $27.93B |
| Total current liabilities | $43.29B | $38.75B | $37.84B | $29.54B | $35.19B |
| Cash & equivalents | $5.23B | $5.52B | $12.81B | $9.20B | $9.75B |
| Marketable securities (current) | $28.0M | $31.0M | $2.0M | $28.0M | $84.0M |
| Accounts receivable | $12.59B | $10.92B | $11.15B | $11.25B | $9.98B |
| Inventory | $4.95B | $4.18B | $4.10B | $3.58B | $3.13B |
| Marketable securities (non-current) | $268.0M | $279.0M | $304.0M | $241.0M | $277.0M |
| Property, plant & equipment | $5.63B | $5.13B | $4.99B | $4.93B | $5.11B |
| Goodwill | $35.64B | $34.96B | $32.29B | $32.16B | $32.38B |
| Intangible assets | $52.64B | $60.07B | $55.61B | $67.44B | $75.95B |
| Other non-current assets | $10.72B | $9.14B | $8.51B | $5.57B | $4.88B |
| Accounts payable | $3.59B | $2.94B | $3.69B | $2.93B | $2.88B |
| Short-term debt | $2.50B | $0 | $0 | $1.0M | $14.0M |
| Long-term debt | $64.50B | $66.84B | $59.24B | $63.13B | $75.96B |
| Other non-current liabilities | $32.57B | $30.13B | $32.33B | $30.66B | $28.70B |
| Retained earnings | -$15.49B | -$7.90B | -$1.00B | $4.78B | $3.13B |
| Accumulated other comprehensive income (loss) | -$1.14B | -$1.93B | -$2.31B | -$2.20B | -$2.90B |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $19.03B | $18.81B | $22.84B | $24.94B | $22.78B |
| Investing cash flow | -$6.64B | -$20.82B | -$2.01B | -$623.0M | -$2.34B |
| Financing cash flow | -$12.72B | -$5.21B | -$17.22B | -$24.80B | -$19.04B |
| Free cash flow | $17.82B | $17.83B | $22.06B | $24.25B | $21.99B |
| Capital expenditures | $1.21B | $974.0M | $777.0M | $695.0M | $787.0M |
| Share-based compensation | $955.0M | $911.0M | $747.0M | $671.0M | $692.0M |
| Deferred income taxes | -$492.0M | -$1.45B | -$2.89B | -$1.93B | -$898.0M |
| Change in accounts receivable | $1.49B | -$207.0M | -$66.0M | $1.46B | $1.32B |
| Change in inventory | $234.0M | $319.0M | $417.0M | $686.0M | $142.0M |
| Purchases of investments | $35.0M | $73.0M | $77.0M | $1.44B | $119.0M |
| Other investing activities | $29.0M | -$189.0M | -$13.0M | -$774.0M | -$366.0M |
| Dividends paid | $11.66B | $11.03B | $10.54B | $10.04B | $9.26B |
| Share repurchases | $980.0M | $1.71B | $1.97B | $1.49B | $934.0M |
| Debt issued | $3.99B | $16.96B | — | $2.00B | $1.00B |
| Other financing activities | $68.0M | $57.0M | $48.0M | $30.0M | $24.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ABBV as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers51.0%
Shares Outstanding1,769,000,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 149,488,412 | $37.62B | 8.45% | -0.8% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 115,396,098 | $29.04B | 6.52% | +0.4% | 2026-06-30 |
| State Street Corp | 82,596,748 | $20.78B | 4.67% | +1.7% | 2026-08-07 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 48,477,996 | $12.20B | 2.74% | -2.1% | 2026-06-30 |
| Jpmorgan Chase & Co | 47,862,796 | $12.17B | 2.71% | -15.6% | 2026-08-12 |
| GEODE CAPITAL MANAGEMENT, LLC | 46,998,433 | $11.81B | 2.66% | +0.6% | 2026-08-12 |
| Morgan Stanley | 38,901,001 | $9.79B | 2.20% | +2.3% | 2026-08-11 |
| Capital Research Global Investors | 30,101,551 | $7.57B | 1.70% | -3.7% | 2026-08-07 |
| NORGES BANK | 25,554,538 | $6.43B | 1.44% | +0.0% | 2026-08-12 |
| Bank Of America Corp /De/ | 21,237,764 | $5.34B | 1.20% | -11.3% | 2026-08-14 |
| FMR LLC | 20,773,786 | $5.23B | 1.17% | -4.5% | 2026-08-13 |
| Northern Trust Corp | 20,558,447 | $5.17B | 1.16% | -3.1% | 2026-08-12 |
| Franklin Resources Inc | 19,925,232 | $5.01B | 1.13% | +36.9% | 2026-08-04 |
| Corient Private Wealth LP | 19,571,862 | $559.7M | 1.11% | +788.2% | 2026-08-12 |
| Capital World Investors | 19,178,966 | $4.83B | 1.08% | +21.1% | 2026-08-07 |
| Goldman Sachs Group Inc | 16,291,630 | $4.10B | 0.92% | +7.6% | 2026-08-14 |
| Capital International Investors | 15,638,631 | $3.94B | 0.88% | +8.5% | 2026-08-07 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 14,749,069 | $3.7M | 0.83% | +13.4% | 2026-08-14 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 14,267,697 | $3.59B | 0.81% | +0.7% | 2026-08-13 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 12,914,230 | $3.25B | 0.73% | -0.4% | 2026-08-14 |
| Sixth Street Partners Management Company, L.P. | 12,914,230 | $3.25B | 0.73% | +0.0% | 2026-08-13 |
| Bank of New York Mellon Corp | 12,853,368 | $3.23B | 0.73% | -3.2% | 2026-08-06 |
| UBS Group AG | 12,845,120 | $3.23B | 0.73% | -8.6% | 2026-08-13 |
| Legal & General Group Plc | 11,548,053 | $2.91B | 0.65% | -5.0% | 2026-08-14 |
| Ameriprise Financial Inc | 11,519,507 | $2.90B | 0.65% | +4.1% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-27 to 2026-08-14
Recent transactions
- Insiders have net sold 32,710 shares over the last 182 days, across 0 purchases and 1 sale.
- Most recent: Donoghoe Nicholas (EVP, CHIEF BUS/STRAT OFFICER) — Option exercise of 32,710 shares on 2026-08-14.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)32,710 sh(1 txns)
Net Shares-32,710
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Option exercise | 2026-08-14 | 32,710 |
| FALK THOMAS J | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| WADDELL FREDERICK H | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| Roberts Rebecca B | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| RAPP EDWARD J | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| Quaggin Susan E | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| MEYER MELODY B | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| Hart Brett J | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| FREYMAN THOMAS C | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| Davis Jennifer L. | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| BURNSIDE WILLIAM H.L. | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| AUSTIN ROXANNE S | Reporting person | Grant / award | 2026-05-08 | 1,118 |
| Purdue David Ryan | SVP, Controller | Open market sale | 2026-03-04 | 5,230 |
| Siatis Perry C | EVP, GC AND SECRETARY | Open market sale | 2026-03-02 | 5,777 |
| Crum Demetris D | EVP, CHIEF HR OFFICER | Tax withholding | 2026-02-27 | 1,594 |
| Thakkar Roopal | EVP, R&D and CSO | Tax withholding | 2026-02-27 | 8,037 |
| Michael Robert A. | CHAIRMAN OF THE BOARD AND CEO | Tax withholding | 2026-02-27 | 36,523 |
| Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Tax withholding | 2026-02-27 | 23,812 |
| Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Tax withholding | 2026-02-27 | 21,638 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-14 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Option exercise | 32,710 | $79.02 |
| 2026-08-14 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Open market sale | 32,710 | $250.00 |
| 2026-05-08 | FALK THOMAS J | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-05-08 | WADDELL FREDERICK H | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-05-08 | Roberts Rebecca B | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-05-08 | RAPP EDWARD J | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-05-08 | Quaggin Susan E | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-05-08 | MEYER MELODY B | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-05-08 | Hart Brett J | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-05-08 | FREYMAN THOMAS C | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-05-08 | Davis Jennifer L. | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-05-08 | BURNSIDE WILLIAM H.L. | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-05-08 | AUSTIN ROXANNE S | Reporting person | Grant / award | 1,118 | $0.00 |
| 2026-03-04 | Purdue David Ryan | SVP, Controller | Open market sale | 5,230 | $233.56 |
| 2026-03-02 | Siatis Perry C | EVP, GC AND SECRETARY | Open market sale | 5,777 | $233.51 |
| 2026-03-02 | Siatis Perry C | EVP, GC AND SECRETARY | Open market sale | 10,291 | $234.66 |
| 2026-03-02 | Siatis Perry C | EVP, GC AND SECRETARY | Open market sale | 2,600 | $235.26 |
| 2026-02-27 | Crum Demetris D | EVP, CHIEF HR OFFICER | Tax withholding | 1,594 | $232.08 |
| 2026-02-27 | Thakkar Roopal | EVP, R&D and CSO | Tax withholding | 8,037 | $232.08 |
| 2026-02-27 | Michael Robert A. | CHAIRMAN OF THE BOARD AND CEO | Tax withholding | 36,523 | $232.08 |
| 2026-02-27 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Tax withholding | 23,812 | $232.08 |
| 2026-02-27 | Siatis Perry C | EVP, GC AND SECRETARY | Tax withholding | 14,850 | $232.08 |
| 2026-02-27 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Tax withholding | 21,638 | $232.08 |
| 2026-02-27 | Purdue David Ryan | SVP, Controller | Tax withholding | 2,692 | $232.08 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-09-03 12:39 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-18 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-18 | 8-K | 2026-08-18 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-04 | View on SEC.gov → |
| 2026-08-03 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-31 | 8-K | 2026-07-31 | View on SEC.gov → |
| 2026-07-06 | 8-K | 2026-07-06 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-06-22 | 8-K | 2026-06-18 | View on SEC.gov → |
| 2026-05-12 | 8-K | 2026-05-08 | View on SEC.gov → |
| 2026-05-12 | 4 | 2026-05-08 | View on SEC.gov → |
| 2026-05-12 | 4 | 2026-05-08 | View on SEC.gov → |
Recent news
Headlines about ABBV (ABBVIE INC.). Links open the publisher — we don’t host full articles.
-
AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Yahoo Finance · 2026-09-03 -
Amgen Stock Signals Its Confidence. The Market Agrees.
Yahoo · 2026-09-02 -
How Did Merck Stock Beat The Market With Slowing Sales?
Yahoo · 2026-09-02 -
No ETFs Required: How a 64-Year-Old Built a $5,700 Monthly Paycheck From Five Dividend Stocks
Yahoo · 2026-09-02 -
Kymera's KT-621 Has 'Oral Dupixent' Potential, but Valuation Limits Upside, RBC Says
Yahoo · 2026-09-02 -
Can LLY's Merida Deal Boost Its M&A Push to Diversify Beyond GLP-1s?
Yahoo · 2026-09-02 -
Allergan Aesthetics Unveils the Layered Beauty Report, Advancing the Global Conversation Around Aesthetic Care
Yahoo · 2026-09-02 -
5 Reasons To Buy Clinuvel Pharmaceuticals After Its Nasdaq Uplisting
SeekingAlpha · 2026-09-02
No headlines in this category right now — try “All”.